Instrumento Inactivo

Otros idiomas Emerald Health Therapeutics

Acciones

EMH

CA29102R1064

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.	09/02/23
C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million.	14/11/22
CSE Bulletin: Delist - Emerald Health Therapeutics, Inc. (EMH)	11/11/22
Skye Bioscience, Inc. completed the acquisition of Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others.	10/11/22
IIROC Trading Halt - EMH	09/11/22
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger	19/10/22
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	30/08/22
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience	29/08/22
Skye Bioscience Reports that CSE-listed Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement	19/08/22
Certain Emerald Health Shareholders Oppose Proposed Merger with Skye Biosciences	04/08/22
Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc.	04/08/22
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order	13/07/22
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results	12/07/22
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	09/07/22
Emerald Health Therapeutics : 2021 Q4	05/07/22
Emerald Health Therapeutics : 2021 - Audited Financial Statements	05/07/22
Emerald Health Therapeutics, Inc. - Reports 2021 Year-end Results and Corporate Update	05/07/22
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/07/22
Emerald Health Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	30/06/22
Skye Bioscience, Inc. entered into term sheet to acquire Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others for CAD 24.4 million.	11/05/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Emerald Health Therapeutics

Acciones

EMH

CA29102R1064

Otros idiomas

Filtros